886 results on '"Malyszko, Jolanta"'
Search Results
102. Biomarkers of iron metabolism in chronic kidney disease
103. Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in CKD: translational opportunities and challenges
104. Cognitive Impairment and Kidney Transplantation: Underestimated, Underrecognized but Clinically Relevant Problem.
105. Author Correction: Lipid management in patients with chronic kidney disease
106. KIDNEY DAMAGE IN PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
107. Acute kidney injury prevalence in patients with colorectal cancer undergoing surgery with curative intent
108. CONTRAST INDUCED ACUTE KIDNEY INJURY IS NOT A SITUATION TO BE AFRAID OF
109. Iron metabolism in chronic kidney disease
110. The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 years
111. Does Lack of ST-Segment Resolution Still Have Prognostic Value 6 Years After an Acute Myocardial Infarction Treated With Coronary Intervention?
112. Current Status of Renal Anemia Pharmacotherapy—What Can We Offer Today
113. Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up
114. Possible Involvement of Serotonin in the Haemostatic Action of DDAVP in Patients with Uraemia
115. Blood Pressure Levels and Stroke: J-curve Phenomenon?
116. Do CHA2DS2VASc and HAS-BLED scores influence ‘real-world’ anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre
117. The fate of triaged and rejected manuscripts
118. Mechanism of endothelial dysfunction in chronic kidney disease
119. Post-Contrast Acute Kidney Injury in Patients with Various Stages of Chronic Kidney Disease—Is Fear Justified?
120. Corrigendum to ‘Simultaneous Liver- Kidney Transplantation and The Use of Intraoperative Dialysis- A Monocenter Study’ [Transplantation Proceedings 54/4 (2022) 1002–1006]
121. Renal Replacement Modality Affects Uremic Toxins and Oxidative Stress
122. Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients
123. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation
124. MO128RETINOL BINDING PROTEIN (RBP) - NEW BIOMARKER OF KIDNEY INJURY IN MULTIPLE MYELOMA PATIENTS*
125. Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients
126. Cardiac device-related endocarditis in the patient with end-stage renal failure in the course of Fabry disease
127. Basilic Vein Transposition in the Forearm for Secondary Arteriovenous Fistula
128. Haematological disorders following kidney transplantation.
129. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.
130. High-resolution computed tomography rather than chest radiography – how pandemic changed our evaluation policy of potential kidney transplant recipients
131. Drug dosing in cancer patients with decreased kidney function: A practical approach
132. NOVEL IRON BIOMARKERS IN CHRONIC KIDNEY DISEASE
133. THE IMPORTANCE OF MENTAL RESILIENCE AGAINST LONELINESS DURING THE COVID-19 PANDEMIC IN DIALYSIS PATIENTS
134. Erratum to: Hematological disorders following kidney transplantation
135. Iron and Chronic Kidney Disease: Still a Challenge
136. The Serum Concentration of Anti-Aging Proteins, Sirtuin1 and αKlotho in Patients with End-Stage Kidney Disease on Maintenance Hemodialysis
137. Thyroid Function, Endothelium, and Inflammation in Hemodialyzed Patients: Possible Relations?
138. Haematological disorders following kidney transplantation
139. Same rhythm, different song—approaches to atrial fibrillation management by cardiologists and nephrologists
140. Fluvastin therapy affects TAFI concentration in kidney transplant recipients
141. Renalase, Hypertension, and Kidney — The Discussion Continues
142. Iron status in patients with chronic heart failure
143. Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA
144. Anemia and Erythrocytosis in patients after kidney transplantation
145. Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges.
146. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
147. Left ventricular morphology and function in diabetic and nondiabetic hemodialyzed patients
148. Renalase as a Possible Risk Factor of Cardiovascular Complications in Hemodialysis
149. Iron Metabolism in Hemodialyzed Patients—Still a Mystery?
150. The link between kidney disease and cancer: complications and treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.